Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001415889-25-015836

Director acquired 12,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. Director 2025-06-04 Grant or award +12,800 12,800 I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2025-06-04 Grant or award · Stock Option (Right to Buy) +19,500 19,500 I
Loading xslF345X05/form4-06052025_100655.xml…